Despite the role of IRF3 in B-ALL is little known, it seems to be linked to B-cell differentiation in the presence of the TEL-AML1 fusion protein, the most common genetic rearrangement reported in B-ALL patients (29). Here, IRF3 is linked to acute lymphoblastic leukemia.